Central Bucks Cardiology is a clinical research site located in Doylestown, Pennsylvania, United States 18901.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Central Bucks Cardiology has participated in 8 clinical trials.
Therapeutic areas: Anti-coagulation Therapy, DVT, Pulmonary Embolism.
Sponsors: Iverson Genetic Diagnostics, Inc., Brigham and Women's Hospital, Boehringer Ingelheim.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Central Bucks Cardiology has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Bucks Cardiology has 8 clinical trials on record. Their work covers Anti-coagulation Therapy, DVT, Pulmonary Embolism.
Yes — Central Bucks Cardiology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.